课题基金 / 基金详情

The role of interferon gamma and nitric oxide as downregulating molecules in central nervous system inflammation

The role of interferon gamma and nitric oxide as downregulating molecules in central nervous system inflammation
干扰素γ和一氧化氮作为下调分子在中枢神经系统炎症中的作用
批准号:
nhmrc : 127600
负责人:
David Willenborg
金额:
$35.12万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2004-12-31

项目摘要

项目成果

David Willenborg的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cytokines are soluble factors which participate in inflammatory responses. Interferon gamma is a cytokine which in the context of central nervous system inflammation has been considered a Obad? molecule, as has the gas nitric oxide which is induced by interferon gamma. We now have direct evidence that indicate quite the contrary, ie interferon gamma and nitric oxide can a do act as down regulators of inflammation. The present work is designed to determine if this down regulating function is restricted only to a single model of CNS inflammation or is a general phenomenon within the CNS. The project will also involve a number of experiments designed to elucidate the mechanism(s) by which down regulation occurs. This project is highly significant in that a single uncontrolled clinical trial of interferon gamma for the therapy of MS has been carried out and reported as indicating that interferon gamma made the disease worse. The design of that trial however was such that the validity of that claim is questionable. If our experiments confirm the general nature of interferon gamma as a down regulator in inflammation in a number of different models of MS then a case for revisiting the use of interferon, or a downstream product of interferon, in the therapy of MS might be made.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ongoing Uncoupled Research Fellowship
  • 批准号:
    nhmrc : 151311
  • 项目类别:
    NHMRC Research Fellowships
  • 资助金额:
    $37.5万
  • 财政年份:
    2001
  • 负责人:
    David Willenborg
  • 依托单位:
国内基金
海外基金
系统性探索不同N-glycan修饰对Interferonβ活性和稳定性影响
  • 批准号:
    21877063
  • 项目类别:
    面上项目
  • 资助金额:
    61.4万元
  • 批准年份:
    2018
  • 负责人:
    王鹏
  • 依托单位:
控制肠道病毒71型感染的先天性免疫保护机制及其应用
干扰素信号分子及其调控网络在抗HBV感染过程中的作用机制研究
  • 批准号:
    81171558
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    宁琴
  • 依托单位:
糖药物蛋白Interferonβ N-glycan的均一、人源化改造
  • 批准号:
    81102361
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2011
  • 负责人:
    程剑松
  • 依托单位: